DE2819859C2 - - Google Patents
Info
- Publication number
- DE2819859C2 DE2819859C2 DE19782819859 DE2819859A DE2819859C2 DE 2819859 C2 DE2819859 C2 DE 2819859C2 DE 19782819859 DE19782819859 DE 19782819859 DE 2819859 A DE2819859 A DE 2819859A DE 2819859 C2 DE2819859 C2 DE 2819859C2
- Authority
- DE
- Germany
- Prior art keywords
- treatment
- horses
- horse
- cromoglycate
- days
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229960000265 cromoglicic acid Drugs 0.000 claims description 19
- 238000011282 treatment Methods 0.000 claims description 14
- 241000283086 Equidae Species 0.000 claims description 12
- 208000023504 respiratory system disease Diseases 0.000 claims description 3
- IMZMKUWMOSJXDT-UHFFFAOYSA-N cromoglycic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 IMZMKUWMOSJXDT-UHFFFAOYSA-N 0.000 claims 1
- VLARUOGDXDTHEH-UHFFFAOYSA-L disodium cromoglycate Chemical compound [Na+].[Na+].O1C(C([O-])=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C([O-])=O)O2 VLARUOGDXDTHEH-UHFFFAOYSA-L 0.000 description 18
- 241001465754 Metazoa Species 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 239000000443 aerosol Substances 0.000 description 5
- 241000282412 Homo Species 0.000 description 4
- 241001134661 Saccharopolyspora rectivirgula Species 0.000 description 4
- 206010002198 Anaphylactic reaction Diseases 0.000 description 3
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 3
- 230000036783 anaphylactic response Effects 0.000 description 3
- 208000003455 anaphylaxis Diseases 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 210000002345 respiratory system Anatomy 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000004604 Blowing Agent Substances 0.000 description 2
- 208000019693 Lung disease Diseases 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- RCKMWOKWVGPNJF-UHFFFAOYSA-N diethylcarbamazine Chemical compound CCN(CC)C(=O)N1CCN(C)CC1 RCKMWOKWVGPNJF-UHFFFAOYSA-N 0.000 description 2
- 229960003974 diethylcarbamazine Drugs 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000003595 mist Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- -1 2-carb oxychromon-5-yloxy Chemical group 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 238000002555 auscultation Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 208000030270 breast disease Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229940047135 glycate Drugs 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229940041682 inhalant solution Drugs 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Feed For Specific Animals (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1899577A GB1592968A (en) | 1977-05-06 | 1977-05-06 | Method of treating animals |
| GB2218677 | 1977-05-26 | ||
| GB2306777 | 1977-06-01 | ||
| GB3384777 | 1977-08-12 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE2819859A1 DE2819859A1 (de) | 1978-11-09 |
| DE2819859C2 true DE2819859C2 (cs) | 1989-08-31 |
Family
ID=27448439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19782819859 Granted DE2819859A1 (de) | 1977-05-06 | 1978-05-05 | Tiermedizinisches behandlungsmittel und inhalationsvorrichtung fuer tiere |
Country Status (5)
| Country | Link |
|---|---|
| AU (1) | AU522209B2 (cs) |
| DE (1) | DE2819859A1 (cs) |
| FR (1) | FR2389376A1 (cs) |
| IE (1) | IE46952B1 (cs) |
| NZ (1) | NZ187192A (cs) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE202015100684U1 (de) | 2015-02-12 | 2015-02-27 | Alf Fahrzeugbau Gmbh & Co Kg | Mobile Behandlungseinrichtung für Tiere |
| EP4132507A4 (en) * | 2020-04-06 | 2024-05-15 | The General Hospital Corporation | METHODS FOR TREATING CORONAVIRUS-INDUCED INFLAMMATORY CONDITIONS |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1144905A (en) * | 1965-03-25 | 1969-03-12 | Fisons Pharmaceuticals Ltd | Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof |
| US3686412A (en) * | 1965-03-25 | 1972-08-22 | Colin Fitzmaurice | Compositions containing bis-chromonyl compounds for inhibiting antigen-antibody reactions |
| DE2448730A1 (de) * | 1973-10-23 | 1975-04-24 | Fisons Ltd | Neue 4-oxo-4h-1-benzopyranderivate und verfahren zu ihrer herstellung |
| IL46028A0 (en) * | 1973-11-21 | 1975-02-10 | Fisons Ltd | Novel chromones and xanthones,their preparation and pharmaceutical compositions containing them |
| GB1488707A (en) * | 1974-07-10 | 1977-10-12 | Fisons Ltd | 5-(2-hydroxy-propoxy)-4-oxo-8-propyl-4h-1-benzopyran-2-carboxylic acid and derivatives thereof |
| DE2537204A1 (de) * | 1974-08-23 | 1976-03-04 | Fisons Ltd | Neue benzopyrane und verfahren zu ihrer herstellung |
| DE2634908A1 (de) * | 1974-11-09 | 1977-04-14 | Fisons Ltd | Mittel zur behandlung chronischer haut- oder augenerkrankungen |
| CA1065329A (en) * | 1974-11-30 | 1979-10-30 | Richard Hazard | Chromone derivatives |
| DE2500656A1 (de) * | 1975-01-09 | 1976-07-15 | Fisons Ltd | Chromonverbindungen enthaltende pharmazeutische praeparate |
-
1978
- 1978-05-05 DE DE19782819859 patent/DE2819859A1/de active Granted
- 1978-05-05 AU AU35842/78A patent/AU522209B2/en not_active Expired
- 1978-05-05 IE IE90878A patent/IE46952B1/en not_active IP Right Cessation
- 1978-05-05 FR FR7813350A patent/FR2389376A1/fr active Granted
- 1978-05-05 NZ NZ18719278A patent/NZ187192A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ187192A (en) | 1982-02-23 |
| FR2389376A1 (en) | 1978-12-01 |
| AU3584278A (en) | 1979-11-08 |
| DE2819859A1 (de) | 1978-11-09 |
| IE46952B1 (en) | 1983-11-16 |
| AU522209B2 (en) | 1982-05-20 |
| FR2389376B1 (cs) | 1982-02-19 |
| IE780908L (en) | 1978-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69721766T2 (de) | Neue arzneiformulierung | |
| DE69822665T2 (de) | Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14-dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen | |
| DE69024672T2 (de) | Sprays zur Behandlung von Infektionen des Tractus Respiratorius | |
| DE69232706T2 (de) | Verfahren zur behandlung infektiöser respiratorischer erkrankungen | |
| DE69018092T2 (de) | Aerosolzubereitung von glutathion und verfahren zur erhöhung des glutathionspiegels in der lunge. | |
| DE2851543A1 (de) | Inhalationspraeparat | |
| DE9014324U1 (de) | Hilfsgerät zur Verwendung mit Aerosolbehältern | |
| EP0133252A1 (de) | Zur Inhalation bestimmte Darreichungsform von Calcium-Antagonisten | |
| EP0125634A1 (de) | Verwendung einer sekretolytisch wirkenden Substanz zur Herstellung eines Antischnarchmittels und zur Bekämpfung des Schnarchphänomens | |
| DE3317530A1 (de) | Antischnarchmittel | |
| DE69527713T2 (de) | Verbindunngen und zusammensetzungen zur verabreichung via inhalation und insufflierung | |
| DE2819859C2 (cs) | ||
| DE2903957A1 (de) | Mittel zur behandlung der nasalen hypersekretion | |
| DE69030584T2 (de) | Verfahren sowie zusammensetzungen zur behandlung mit vitaminmineral | |
| EP0571457B1 (de) | Iloprost mit wirkung gegen cerebrale malaria | |
| DE19681207B4 (de) | Therapeutische Verwendung von Rubidiumionen und Zubereitungen | |
| DE69125204T2 (de) | Therapeutische Anwendung von Histamin-H3-Agonisten, neue Wirkstoffe und Verwendung zur Herstellung von Arzneimitteln | |
| DE3116211A1 (de) | "nonaprenylamin-derivate und sie enthaltende pharmazeutische mittel" | |
| DE2929009A1 (de) | Gegen bakterielle erkrankungen wirksame zubereitung | |
| DE3852717T2 (de) | Zusammensetzung für die Prophylaxe von Pneumocystis-carinii-Pneumonie. | |
| DE69312473T2 (de) | Zerstäubungsvorrichtung von therapeutischen Substanzen | |
| DE2134899C3 (de) | Verwendung von N-Äthyl-norscopolaminmethobromid | |
| DE3116250C2 (cs) | ||
| DE2749075C2 (cs) | ||
| DE3626306A1 (de) | Verwendung von 15-deoxyspergualin als arzneimittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8127 | New person/name/address of the applicant |
Owner name: FISONS PLC, IPSWICH, SUFFOLK, GB |
|
| 8128 | New person/name/address of the agent |
Representative=s name: WUESTHOFF, F., DR.-ING. FRHR. VON PECHMANN, E., DI |
|
| 8110 | Request for examination paragraph 44 | ||
| 8172 | Supplementary division/partition in: |
Ref country code: DE Ref document number: 2858358 Format of ref document f/p: P |
|
| Q171 | Divided out to: |
Ref country code: DE Ref document number: 2858358 |
|
| D2 | Grant after examination | ||
| 8363 | Opposition against the patent | ||
| 8331 | Complete revocation |